
    
      This is an investigator-initiated, single-site study, consisting of two phases: 8 weeks of
      open-label treatment with sertraline (50mg-150mg/day) in patients iwth OCD.At week 8, those
      who have failed to achieve remission will be continued on sertraline and will be randomized
      to receive Levetiracetam (500mg-2000mg/day) or Placebo for 8 weeks.
    
  